Evolus (NASDAQ:EOLS) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.13) by 23.08 percent. This is a 6.67 percent decrease over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $73.137 million which beat the analyst consensus estimate of $72.288 million by 1.17 percent. This is a 6.77 percent increase over sales of $68.500 million the same period last year.